FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Titel:
FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
Auteur:
Oliveira, M. Saura, C. Nuciforo, P. Calvo, I. Andersen, J. Passos-Coelho, J.L. Gil Gil, M. Bermejo, B. Patt, D.A. Ciruelos, E. de la Peña, L. Xu, N. Wongchenko, M. Shi, Z. Singel, S.M. Isakoff, S.J.